<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100896">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02003859</url>
  </required_header>
  <id_info>
    <org_study_id>SCCH-001</org_study_id>
    <nct_id>NCT02003859</nct_id>
  </id_info>
  <brief_title>Predictive Value of pCLE Findings in Pediatric IBD</brief_title>
  <official_title>Predictive Value of pCLE Findings in Pediatric IBD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scientific Center of Children's Health RAMS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Scientific Center of Children's Health RAMS</source>
  <oversight_info>
    <authority>Russia: Ministry of Health of the Russian Federation</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies over the past two decades have convincingly demonstrated the role of barrier
      dysfunction in the pathogenesis of inflammatory bowel disease. It previously shown that
      optical biopsy with probe-based confocal laser endomicroscopy (pCLE) could be used to assess
      mucosal barrier function. Furthermore, mucosal barrier dysfunction on pCLE was shown to be
      predictive of disease relapse in adult IBD patients. The purpose of the current study is to
      determine the predictive value of pCLE findings in pediatric IBD patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Primary study end-point was moderate to severe flare requiring hospitalization after pCLE</measure>
    <time_frame>follow up period was a median of 18 months (range 4 to 33)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Optical biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients with IBD from all over Russia, treated from IBD in our Center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed informed consent

          -  patients with established IBD

        Exclusion Criteria:

          -  Any kind of allergy

          -  Bronchial asthma

          -  Liver or kidney disease

          -  Inability to sign informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrey A Shavrov, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>The Scientififc Center of Children's Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anton A Shavrov, M.D.</last_name>
    <phone>+7(916)4364099</phone>
    <email>shavrovnczd@yandex.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Scientific Center of Children's Health</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>November 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scientific Center of Children's Health RAMS</investigator_affiliation>
    <investigator_full_name>Anton A. Shavrov</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>IBD</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>pCLE</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
